Product Information
LISDEXAMFETAMINE 50 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.8866 per EA under NDC 00480356901. Its NADAC has been published 75 times since Jan 22, 2025.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480356901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202802On Market Since
12/17/2024
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has been published 75 times since Jan 22, 2025, and over the history we have for it it has declined 43.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8866 per EA |
|---|---|
| All-time high | $5.1144 (Feb 12, 2025) |
| All-time low | $2.7928 (Apr 22, 2026) |
| 52-week high | $4.1390 |
| 52-week low | $2.7928 |
| Median price | $3.5619 |
| Average price | $3.6929 |
| Largest weekly change | -6.0% (Jun 18, 2025) |
| Weeks tracked | 75 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 50 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.8866 per EA (NDC 00480356901), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has declined 43.6%. It has been tracked across 75 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 50 MG CAPSULE?
Since Jan 22, 2025, the NADAC for LISDEXAMFETAMINE 50 MG CAPSULE has ranged from a low of $2.7928 (Apr 22, 2026) to a high of $5.1144 (Feb 12, 2025), with a median of $3.5619 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 50 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as LISDEXAMFETAMINE 50 MG CAPSULE, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 50 MG CAPSULE?
LISDEXAMFETAMINE 50 MG CAPSULE (NDC 00480356901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification